$ Value
$739K
Shares
30,078
Price
$25
Filed
Apr 6
Insider
Name
Evans John M.
Title
CEO
CIK
0001786304
Roles
Transaction Details
Transaction Date
2026-04-01
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,047,205
Footnotes
These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan on each of March 31, 2022, March 31, 2023, March 31, 2024 and March 31, 2025. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023. | Includes 616 shares acquired by the Reporting Person under the BEAM Amended and Restated 2019 Employee Stock Purchase Plan on March 31, 2026.
Filing Info
Evans John M.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | BEAM | ▼ | $739K |
| 2026-03-31 | BEAM | M | $17K |
| 2026-03-31 | BEAM | ▼ | $569K |
| 2026-03-31 | BEAM | A | $0 |
| 2026-03-31 | BEAM | M | $0 |
| 2026-03-30 | BEAM | M | $17K |
| 2026-03-30 | BEAM | ▼ | $559K |
| 2026-03-30 | BEAM | M | $0 |
| 2025-10-02 | BEAM | M | $17K |
| 2025-10-02 | BEAM | ▼ | $616K |
Other Insiders at BEAM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Evans John M.
CEO
|
— | $1.1M | 2026-03-31 |
|
Ciaramella Giuseppe
President
|
— | $290K | 2026-04-01 |
|
Emany Sravan Kumar
Chief Financial Officer
|
— | — | 2026-03-31 |
|
Bellon Christine
Chief Legal Officer
|
— | $146K | 2026-04-01 |
|
Simon Amy
Chief Medical Officer
|
— | $165K | 2026-04-01 |
|
Cavanagh Bethany J
SVP, Finance and Treasurer
|
— | $80K | 2026-04-01 |